14-day Premium Trial Subscription Try For FreeTry Free
Currently predicting for Mon, 6 May 2024

Trading levels for JANX

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 69.52 7.32 %
R2 67.12 3.61 %
R1 65.63 1.32 %
Current price: 64.78
Support S1 60.83 -6.10 %
S2 59.34 -8.39 %
S3 56.94 -12.10 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0 .
R2 0 .
R1 0 .
Current price 64.78
Support S1 56.08 -13.43%
S2 50.00 -22.82%
S3 49.75 -23.20%

JANX Predictions History

1 week ago
AlexVel predicted that JANX for Apr. 26th is going $46.67 (-1.52%)

1 week ago
PredictionBot.Kathy predicted that JANX for Apr. 22nd is going $50.22 (2.74%)

1 week ago
PredictionBot.Warren predicted that JANX for Apr. 22nd is going $49.65 (1.57%)

2 weeks ago
jasonbourell22.422869 predicted that JANX for Apr. 22nd is going $54.00 (10.91%)

Rank:

2 weeks ago
PredictionBot.Kathy predicted that JANX for Apr. 15th is going $50.95 (-1.75%)

2 weeks ago
PredictionBot.Warren predicted that JANX for Apr. 15th is going $51.59 (-0.52%)

2 weeks ago
theodore.a.royce predicted that JANX for Apr. 15th is going

Rank:

2 weeks ago
JS predicted that JANX for Apr. 15th is going $53.48 (3.12%)

Click to get the best stock tips daily for free!

About Janux Therapeutics, Inc.

Janux Therapeutics. Janux Therapeutics, Inc., a biopharmaceutical company, develops therapeutics based on proprietary Tumor Activated T Cell Engager (TRACTr) platform technology to treat patients suffering from cancer. The company's lead TRACTr product candidates that are in preclinical or discovery stage target prostate-specific membrane antigen, epidermal growth factor receptor, and trophoblast cell surface antigen 2. Janux Therapeutics, Inc. is also developing a ... JANX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT